Nightingale Biomarker-Disease Atlas

About Nightingale Atlas

Blood lipids and metabolites are markers of current health status and can reflect the risk for future disease onset. This webtool provides an open access to results from a disease-wide association scan of 249 plasma biomarkers quantified by Nightingale Health Plc. for ~120,000 participants in the UK Biobank.

The biomarkers cover 249 measures of lipoprotein subclasses, fatty acids, and small molecules, such as amino acids, ketones, and glycolysis metabolites. This online atlas provides the results of systematic analyses of these blood biomarkers with the incidence, prevalence and mortality of 726 diseases (3-character ICD-10 codes with > 50 events in electronic health records up to 12 years after blood sampling).

Details of the analysis and data are described in the related publication:
Julkunen et al. Atlas of plasma NMR biomarkers for health and disease in 118,444 individuals from the UK Biobank. Nature Communications (2023).

Nightingale Health’s technology is routinely used in world-class epidemiological and genetic studies. There are over 350 publications that have utilized our technology. If you are interested in using our technology for medical research, contact us.